6-N-(2,4-dinitrophenyl)aminohexanoic acid: ligand used in prosthetic-group-label immunoassay technique
N-(2,4-dinitrophenyl)aminohexanoic acid : A C-nitro compound comprising hexanoic acid with a (2,4-dinitrophenyl)amino substituent at position C-6.
ID Source | ID |
---|---|
PubMed CID | 96812 |
CHEBI ID | 53698 |
SCHEMBL ID | 37830 |
MeSH ID | M0099541 |
Synonym |
---|
10466-72-5 |
nsc89627 |
nsc-89627 |
dnp-aminocaproic acid |
dnp-epsilon-amino-n-caproic acid |
STK806547 |
6-(2,4-dinitroanilino)hexanoic acid |
AKOS000805794 |
CHEBI:53698 |
dnp-epsilon-aminocaproate |
dnp-cap |
2,4-dinitrophenyl-epsilon-aminocaproic acid |
6-[(2,4-dinitrophenyl)amino]hexanoic acid |
dnp caproic acid |
n-(2,4-dinitrophenyl)aminohexanoic acid |
6-n-(2,4-dinitrophenyl)aminohexanoic acid |
6-(2,4-dinitroanilino)hexansaeure |
D2254 |
n-dnp-6-aminohexanoic acid |
n-(2,4-dinitrophenyl)-6-aminohexanoic acid |
6-(2,4-dinitrophenyl)aminohexanoic acid |
nsc 89627 |
unii-c9dmk9da99 |
hexanoic acid, 6-((2,4-dinitrophenyl)amino)- |
c9dmk9da99 , |
FT-0629089 |
SCHEMBL37830 |
dnp-x acid |
6-((2,4-dinitrophenyl)amino)hexanoic acid |
DTXSID20146636 |
J-001220 |
dnp-?-amino-n-caproic acid |
mfcd00038470 |
6-(2,4-dinitrophenyl) amino hexanoic acid |
6-(2,4-dinitrophenylamino)hexanoic acid |
n-(2,4-dinitrophenyl)-6-aminohexanoicacid |
F12366 |
MS-20991 |
Q27124172 |
HY-D1049 |
CS-0100565 |
6-((2,4-dinitrophenyl)amino)hexanoicacid |
A898001 |
PD158035 |
dinitrophenyl-.epsilon.-aminocaproic acid |
dnp-.epsilon.-amino-n-caproic acid |
((2,4-dinitrophenyl)amino)caproic acid |
dnp- epsilon -amino-n-caproic acid |
AKOS040744068 |
Class | Description |
---|---|
C-nitro compound | A nitro compound having the nitro group (-NO2) attached to a carbon atom. |
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res] |
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 4 (80.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (20.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (12.53) All Compounds (24.57) |
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 5 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |